Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases.

Singhania A, Graham CM, Gabryšová L, Moreira-Teixeira L, Stavropoulos E, Pitt JM, Chakravarty P, Warnatsch A, Branchett WJ, Conejero L, Lin JW, Davidson S, Wilson MS, Bancroft G, Langhorne J, Frickel E, Sesay AK, Priestnall SL, Herbert E, Ioannou M, Wang Q, Humphreys IR, Dodd J, Openshaw PJM, Mayer-Barber KD, Jankovic D, Sher A, Lloyd CM, Baldwin N, Chaussabel D, Papayannopoulos V, Wack A, Banchereau JF, Pascual VM, O'Garra A.

Nat Commun. 2019 Jun 28;10(1):2887. doi: 10.1038/s41467-019-10601-6.

2.

Genome Resequencing of Laboratory Stocks of Burkholderia pseudomallei K96243.

Wagley S, Scott AE, Ireland PM, Prior JL, Atkins TP, Bancroft GJ, Studholme DJ, Titball RW.

Microbiol Resour Announc. 2019 Feb 28;8(9). pii: e01529-18. doi: 10.1128/MRA.01529-18. eCollection 2019 Feb.

3.

Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.

Sawutdeechaikul P, Cia F, Bancroft G, Wanichwecharungruang S, Sittplangkoon C, Palaga T.

J Microbiol Biotechnol. 2019 Mar 28;29(3):489-499. doi: 10.4014/jmb.1809.09049.

4.

Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization.

Kewcharoenwong C, Prabowo SA, Bancroft GJ, Fletcher HA, Lertmemongkolchai G.

Front Immunol. 2018 Sep 19;9:2109. doi: 10.3389/fimmu.2018.02109. eCollection 2018.

5.

Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.

Pinweha P, Pumirat P, Cuccui J, Jitprasutwit N, Muangsombut V, Srinon V, Boonyuen U, Thiennimitr P, Vattanaviboon P, Cia F, Willcocks S, Bancroft GJ, Wren BW, Korbsrisate S.

PLoS One. 2018 May 17;13(5):e0196202. doi: 10.1371/journal.pone.0196202. eCollection 2018.

6.

Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?

Titball RW, Burtnick MN, Bancroft GJ, Brett P.

Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Review.

7.

A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.

Wagley S, Vanaporn M, Rinchai D, Conejero L, Lertmemongkolchai G, Bancroft GJ, Titball RW.

Microb Pathog. 2017 Jun;107:175-180. doi: 10.1016/j.micpath.2017.03.015. Epub 2017 Mar 18.

8.

Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei.

Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, Bancroft GJ, Lertmemongkolchai G.

Sci Rep. 2017 Feb 20;7:42791. doi: 10.1038/srep42791.

9.

Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Nithichanon A, Gourlay LJ, Bancroft GJ, Ato M, Takahashi Y, Lertmemongkolchai G.

Immunology. 2017 May;151(1):98-109. doi: 10.1111/imm.12709. Epub 2017 Feb 9.

10.

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.

Kewcharoenwong C, Rinchai D, Nithichanon A, Bancroft GJ, Ato M, Lertmemongkolchai G.

Sci Rep. 2016 Oct 7;6:34794. doi: 10.1038/srep34794.

11.

Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages.

Howes A, Taubert C, Blankley S, Spink N, Wu X, Graham CM, Zhao J, Saraiva M, Ricciardi-Castagnoli P, Bancroft GJ, O'Garra A.

J Immunol. 2016 Oct 1;197(7):2838-53. doi: 10.4049/jimmunol.1501923. Epub 2016 Aug 22.

12.

CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.

Sayes F, Pawlik A, Frigui W, Gröschel MI, Crommelynck S, Fayolle C, Cia F, Bancroft GJ, Bottai D, Leclerc C, Brosch R, Majlessi L.

PLoS Pathog. 2016 Jul 28;12(7):e1005770. doi: 10.1371/journal.ppat.1005770. eCollection 2016 Jul.

13.

Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis.

Casey WT, Spink N, Cia F, Collins C, Romano M, Berisio R, Bancroft GJ, McClean S.

Vaccine. 2016 May 17;34(23):2616-21. doi: 10.1016/j.vaccine.2016.03.088. Epub 2016 Apr 16.

PMID:
27091689
14.

Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease.

Champion OL, Gourlay LJ, Scott AE, Lassaux P, Conejero L, Perletti L, Hemsley C, Prior J, Bancroft G, Bolognesi M, Titball RW.

Vaccine. 2016 Mar 29;34(14):1665-71. doi: 10.1016/j.vaccine.2016.02.038. Epub 2016 Feb 23.

15.

Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.

Moule MG, Spink N, Willcocks S, Lim J, Guerra-Assunção JA, Cia F, Champion OL, Senior NJ, Atkins HS, Clark T, Bancroft GJ, Cuccui J, Wren BW.

Infect Immun. 2015 Dec 28;84(3):701-10. doi: 10.1128/IAI.01102-15.

16.

Burkholderia pseudomallei kynB plays a role in AQ production, biofilm formation, bacterial swarming and persistence.

Butt A, Halliday N, Williams P, Atkins HS, Bancroft GJ, Titball RW.

Res Microbiol. 2016 Apr;167(3):159-67. doi: 10.1016/j.resmic.2015.11.002. Epub 2015 Nov 30.

PMID:
26654915
17.

The Blood Transcriptome of Experimental Melioidosis Reflects Disease Severity and Shows Considerable Similarity with the Human Disease.

Conejero L, Potempa K, Graham CM, Spink N, Blankley S, Salguero FJ, Pankla-Sranujit R, Khaenam P, Banchereau JF, Pascual V, Chaussabel D, Lertmemongkolchai G, O'Garra A, Bancroft GJ.

J Immunol. 2015 Oct 1;195(7):3248-3261. doi: 10.4049/jimmunol.1500641. Epub 2015 Aug 26.

18.

Consensus on the development of vaccines against naturally acquired melioidosis.

Limmathurotsakul D, Funnell SG, Torres AG, Morici LA, Brett PJ, Dunachie S, Atkins T, Altmann DM, Bancroft G, Peacock SJ; Steering Group on Melioidosis Vaccine Development.

Emerg Infect Dis. 2015 Jun;21(6). doi: 10.3201/eid2106.141480.

19.

The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.

Bancroft EK, Castro E, Bancroft GA, Ardern-Jones A, Moynihan C, Page E, Taylor N, Eeles RA, Rowley E, Cox K.

Psychooncology. 2015 Nov;24(11):1492-9. doi: 10.1002/pon.3814. Epub 2015 Apr 14.

PMID:
25872100
20.

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.

Bottai D, Frigui W, Clark S, Rayner E, Zelmer A, Andreu N, de Jonge MI, Bancroft GJ, Williams A, Brodin P, Brosch R.

Vaccine. 2015 May 28;33(23):2710-8. doi: 10.1016/j.vaccine.2015.03.083. Epub 2015 Apr 11.

PMID:
25869896
21.

T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.

Reynolds C, Goudet A, Jenjaroen K, Sumonwiriya M, Rinchai D, Musson J, Overbeek S, Makinde J, Quigley K, Manji J, Spink N, Yos P, Wuthiekanun V, Bancroft G, Robinson J, Lertmemongkolchai G, Dunachie S, Maillere B, Holden M, Altmann D, Boyton R.

J Immunol. 2015 May 15;194(10):4814-24. doi: 10.4049/jimmunol.1402862. Epub 2015 Apr 10.

22.

Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions.

Buddhisa S, Rinchai D, Ato M, Bancroft GJ, Lertmemongkolchai G.

J Immunol. 2015 May 1;194(9):4413-21. doi: 10.4049/jimmunol.1402417. Epub 2015 Mar 23.

23.

Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.

Sander P, Clark S, Petrera A, Vilaplana C, Meuli M, Selchow P, Zelmer A, Mohanan D, Andreu N, Rayner E, Dal Molin M, Bancroft GJ, Johansen P, Cardona PJ, Williams A, Böttger EC.

Vaccine. 2015 Mar 10;33(11):1353-9. doi: 10.1016/j.vaccine.2015.01.058. Epub 2015 Feb 2.

PMID:
25657094
24.

CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Musson JA, Reynolds CJ, Rinchai D, Nithichanon A, Khaenam P, Favry E, Spink N, Chu KK, De Soyza A, Bancroft GJ, Lertmemongkolchai G, Maillere B, Boyton RJ, Altmann DM, Robinson JH.

J Immunol. 2014 Dec 15;193(12):6041-9. doi: 10.4049/jimmunol.1402273. Epub 2014 Nov 12.

25.

Factors associated with atrial fibrillation in rheumatic mitral stenosis.

Pourafkari L, Ghaffari S, Bancroft GR, Tajlil A, Nader ND.

Asian Cardiovasc Thorac Ann. 2015 Jan;23(1):17-23. doi: 10.1177/0218492314530134. Epub 2014 Apr 2.

PMID:
24696100
26.

Raised levels of metal ions in the blood in patients who have undergone uncemented metal-on-polyethylene Trident-Accolade total hip replacement.

Craig P, Bancroft G, Burton A, Collier S, Shaylor P, Sinha A.

Bone Joint J. 2014 Jan;96-B(1):43-7. doi: 10.1302/0301-620X.96B1.30923. Erratum in: Bone Joint J. 2014 Apr;96-B(4):562.

PMID:
24395309
27.

Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.

Kewcharoenwong C, Rinchai D, Utispan K, Suwannasaen D, Bancroft GJ, Ato M, Lertmemongkolchai G.

Sci Rep. 2013 Nov 28;3:3363. doi: 10.1038/srep03363.

28.

The condition-dependent transcriptional landscape of Burkholderia pseudomallei.

Ooi WF, Ong C, Nandi T, Kreisberg JF, Chua HH, Sun G, Chen Y, Mueller C, Conejero L, Eshaghi M, Ang RM, Liu J, Sobral BW, Korbsrisate S, Gan YH, Titball RW, Bancroft GJ, Valade E, Tan P.

PLoS Genet. 2013;9(9):e1003795. doi: 10.1371/journal.pgen.1003795. Epub 2013 Sep 12.

29.

Application of dual mask for postoperative respiratory support in obstructive sleep apnea patient.

Porhomayon J, Zadeii G, Nader ND, Bancroft GR, Yarahamadi A.

Case Rep Anesthesiol. 2013;2013:321054. doi: 10.1155/2013/321054. Epub 2013 Apr 10.

30.

Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.

Andreu N, Zelmer A, Sampson SL, Ikeh M, Bancroft GJ, Schaible UE, Wiles S, Robertson BD.

J Antimicrob Chemother. 2013 Sep;68(9):2118-27. doi: 10.1093/jac/dkt155. Epub 2013 Apr 30.

31.

Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.

Pitt JM, Stavropoulos E, Redford PS, Beebe AM, Bancroft GJ, Young DB, O'Garra A.

J Immunol. 2012 Oct 15;189(8):4079-87. doi: 10.4049/jimmunol.1201061. Epub 2012 Sep 12.

32.

Production of interleukin-27 by human neutrophils regulates their function during bacterial infection.

Rinchai D, Khaenam P, Kewcharoenwong C, Buddhisa S, Pankla R, Chaussabel D, Bancroft GJ, Lertmemongkolchai G.

Eur J Immunol. 2012 Dec;42(12):3280-90. doi: 10.1002/eji.201242526. Epub 2012 Oct 25.

33.

Is prophylactic Gentamicin associated with acute kidney injury in patients undergoing surgery for fractured neck of femur?

Craig P, Starks I, Bancroft G, Roberts P.

Injury. 2012 Dec;43(12):2152-5. doi: 10.1016/j.injury.2012.08.005. Epub 2012 Aug 17.

PMID:
22906918
34.

Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity.

Müller CM, Conejero L, Spink N, Wand ME, Bancroft GJ, Titball RW.

Infect Immun. 2012 Sep;80(9):3247-55. doi: 10.1128/IAI.00178-12. Epub 2012 Jul 9.

35.

The effect of care bundle development on surgical site infection after hemiarthroplasty: an 8-year review.

Johnson B, Starks I, Bancroft G, Roberts PJ.

J Trauma Acute Care Surg. 2012 May;72(5):1375-9. doi: 10.1097/TA.0b013e318245267c.

PMID:
22673269
36.

A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.

Zelmer A, Carroll P, Andreu N, Hagens K, Mahlo J, Redinger N, Robertson BD, Wiles S, Ward TH, Parish T, Ripoll J, Bancroft GJ, Schaible UE.

J Antimicrob Chemother. 2012 Aug;67(8):1948-60. doi: 10.1093/jac/dks161. Epub 2012 May 25.

37.

Development of vaccines against burkholderia pseudomallei.

Patel N, Conejero L, De Reynal M, Easton A, Bancroft GJ, Titball RW.

Front Microbiol. 2011 Sep 27;2:198. doi: 10.3389/fmicb.2011.00198. eCollection 2011.

38.

Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.

Easton A, Haque A, Chu K, Patel N, Lukaszewski RA, Krieg AM, Titball RW, Bancroft GJ.

J Infect Dis. 2011 Aug 15;204(4):636-44. doi: 10.1093/infdis/jir301.

39.

Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, Titball RW, Salguero FJ, Bancroft GJ.

Am J Pathol. 2011 Jul;179(1):270-80. doi: 10.1016/j.ajpath.2011.03.031. Epub 2011 May 5.

40.

Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis.

Suwannasaen D, Mahawantung J, Chaowagul W, Limmathurotsakul D, Felgner PL, Davies H, Bancroft GJ, Titball RW, Lertmemongkolchai G.

J Infect Dis. 2011 Apr 1;203(7):1002-11. doi: 10.1093/infdis/jiq142. Epub 2011 Feb 7.

41.

A review of 202 periprosthetic fractures--stem revision and allograft improves outcome for type B fractures.

Pavlou G, Panteliadis P, Macdonald D, Timperley JA, Gie G, Bancroft G, Tsiridis E.

Hip Int. 2011 Jan-Mar;21(1):21-9.

PMID:
21298624
42.

CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Chu KK, Tippayawat P, Walker NJ, Harding SV, Atkins HS, Maillere B, Bancroft GJ, Lertmemongkolchai G, Altmann DM.

Eur J Immunol. 2011 Jan;41(1):107-15. doi: 10.1002/eji.201040881. Epub 2010 Dec 3.

43.

Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Tippayawat P, Pinsiri M, Rinchai D, Riyapa D, Romphruk A, Gan YH, Houghton RL, Felgner PL, Titball RW, Stevens MP, Galyov EE, Bancroft GJ, Lertmemongkolchai G.

Infect Immun. 2011 Jan;79(1):305-13. doi: 10.1128/IAI.00803-10. Epub 2010 Nov 1.

44.

Protective cellular responses to Burkholderia mallei infection.

Rowland CA, Lever MS, Griffin KF, Bancroft GJ, Lukaszewski RA.

Microbes Infect. 2010 Oct;12(11):846-53. doi: 10.1016/j.micinf.2010.05.012. Epub 2010 Jun 11.

PMID:
20542133
45.

Optimisation of bioluminescent reporters for use with mycobacteria.

Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, Ripoll J, Parish T, Bancroft GJ, Schaible U, Robertson BD, Wiles S.

PLoS One. 2010 May 24;5(5):e10777. doi: 10.1371/journal.pone.0010777.

46.

Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung.

Redford PS, Boonstra A, Read S, Pitt J, Graham C, Stavropoulos E, Bancroft GJ, O'Garra A.

Eur J Immunol. 2010 Aug;40(8):2200-10. doi: 10.1002/eji.201040433.

47.

Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters.

Carroll P, Schreuder LJ, Muwanguzi-Karugaba J, Wiles S, Robertson BD, Ripoll J, Ward TH, Bancroft GJ, Schaible UE, Parish T.

PLoS One. 2010 Mar 23;5(3):e9823. doi: 10.1371/journal.pone.0009823.

48.

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis.

Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, Banchereau J, Lertmemongkolchai G, Chaussabel D.

Genome Biol. 2009;10(11):R127. doi: 10.1186/gb-2009-10-11-r127. Epub 2009 Nov 10.

49.

A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens.

Felgner PL, Kayala MA, Vigil A, Burk C, Nakajima-Sasaki R, Pablo J, Molina DM, Hirst S, Chew JS, Wang D, Tan G, Duffield M, Yang R, Neel J, Chantratita N, Bancroft G, Lertmemongkolchai G, Davies DH, Baldi P, Peacock S, Titball RW.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13499-504. doi: 10.1073/pnas.0812080106. Epub 2009 Jul 28.

50.

Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.

Tippayawat P, Saenwongsa W, Mahawantung J, Suwannasaen D, Chetchotisakd P, Limmathurotsakul D, Peacock SJ, Felgner PL, Atkins HS, Titball RW, Bancroft GJ, Lertmemongkolchai G.

PLoS Negl Trop Dis. 2009;3(4):e407. doi: 10.1371/journal.pntd.0000407. Epub 2009 Apr 7.

Supplemental Content

Loading ...
Support Center